Maravai Lifesciences Holdings (MRVI) EPS (Basic) (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly EPS (Basic) of -$0.04 for Q1 2026, up 88.18% year-over-year from -$0.02 in Q1 2025, and up 90.02% quarter-over-quarter from -$0.44 in Q4 2025.
Powered by 
Analysis
Maravai Lifesciences Holdings (MRVI) EPS (Basic) (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.04 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 88.18% year-over-year to -$0.04; the TTM figure through Mar 2026 stood at -$1.26 (up 37.71% YoY), while the FY2025 annual figure was -$1.6, up 15.09% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.04, up from -$0.44 in the prior quarter.
- The five-year high for EPS (Basic) was $1.19 in Q2 2022, with the low at -$1.22 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.14 (2024), against an average of -$0.05.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) plunged 1574.94% in 2024, then soared 88.18% in 2026.
- Maravai Lifesciences Holdings' EPS (Basic) stood at $0.66 in 2022, then sank by 225.44% to -$0.83 in 2023, then surged by 59.93% to -$0.33 in 2024, then sank by 30.67% to -$0.44 in 2025, then jumped by 90.02% to -$0.04 in 2026.
- Business Quant data shows MRVI's EPS (Basic) at -$0.04 in Q1 2026, -$0.44 in Q4 2025, and -$0.31 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn | -0.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15 |
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.44 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.33 |
| Sep 30, 2024 | -1.22 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 1.19 |
| Mar 31, 2022 | 1.12 |
| Dec 31, 2021 | 1.11 |
| Sep 30, 2021 | 1.12 |